Paper Details

  1. Home
  2. Paper Details

Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.

Author: BarbaD, EspositoS, GalanteD, RuffilliM P

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Sulbactam/ampicillin was effective in treating urinary, respiratory, biliary tract, or soft tissue infections in 41 patients with chronic liver disease. The combination was well tolerated, with a low number of side effects reported.
Paper Details　
Original Abstract of the Article :
Sulbactam is a new beta-lactamase inhibitor with pharmacokinetic characteristics in humans similar to those of ampicillin. A total of 41 patients hospitalized in the Clinic of Infectious Diseases, University of Naples, for chronic liver diseases, were treated with sulbactam/ampicillin (ratio 1:2) fo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/jac/19.4.527

データ提供：米国国立医学図書館（NLM）

Sulbactam/Ampicillin: An Effective Treatment for Infections in Chronic Liver Disease

This study investigates the clinical efficacy and safety of sulbactam/ampicillin in patients with chronic liver disease. It's like exploring the effectiveness of different strategies for restoring a desert ecosystem, seeking the most suitable solutions for specific conditions. The authors focus on the use of sulbactam/ampicillin for treating various infections in patients with chronic liver disease, akin to identifying the most effective irrigation methods to revitalize a parched landscape.

Addressing the Unique Challenges of Liver Disease

The study highlights the need for effective antibiotic therapies to address infections in patients with chronic liver disease. It's like understanding the delicate balance of the desert ecosystem, recognizing that specific treatments are needed for specific conditions. The authors' findings demonstrate the effectiveness of sulbactam/ampicillin in treating infections, akin to discovering a new water source that revitalizes a struggling oasis.

Optimizing Treatment for Liver Disease Patients

The research emphasizes the importance of choosing appropriate antibiotics for patients with chronic liver disease. It's like selecting the right tools for a desert expedition, ensuring that the chosen strategies are effective and well-suited to the specific challenges of the environment. The study suggests that sulbactam/ampicillin offers a valuable treatment option, providing hope for patients who are vulnerable to infections.

Dr.Camel's Conclusion

This research provides valuable insights into the treatment of infections in patients with chronic liver disease. It's like a desert guide, sharing their knowledge of the landscape and providing effective solutions for navigating challenging conditions. The study highlights the effectiveness of sulbactam/ampicillin, offering hope for patients facing the complexities of chronic liver disease.

Date :
  1. Date Completed 1987-07-17
  2. Date Revised 2019-05-10
Further Info :

Pubmed ID

3034850

DOI: Digital Object Identifier

10.1093/jac/19.4.527

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.